MGNX

Macrogenics Inc

• TipRanks·3d ago

  MacroGenics Shareholders Back Board, Auditors and Equity Plan

• PUBT·3d ago

  MacroGenics shareholders approved 1.25 million-share increase to 2023 equity plan

• Simply Wall St·05/14 23:30

  MacroGenics (MGNX) Quarterly Loss Of US$36.8 Million Tests Bullish Path To Profitability

• TipRanks·05/14 13:11

  Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), Rapid Micro Biosystems (RPID) and MacroGenics (MGNX)

• TipRanks·05/14 09:25

  Barclays Reaffirms Their Buy Rating on MacroGenics (MGNX)

• Benzinga·05/13 20:56

  Macrogenics Q1 EPS $(0.58) Beats $(0.65) Estimate, Sales $20.775M Beat $15.050M Estimate

• Reuters·05/13 20:13

  MacroGenics Q1 revenue rises, beats estimates on client production and cancer drug royalties  

• Seeking Alpha·05/13 20:06

  MacroGenics GAAP EPS of -$0.58 misses by $0.03, revenue of $20.78M beats by $5.54M

• Dow Jones·05/13 20:02

  *Macrogenics Cash, Cash Equivalents and Marketable Securities Balance of $154.2 M as of March 31 >MGNX

• Reuters·05/13 20:01

  MACROGENICS REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS AND HIGHLIGHTS BUSINESS TRANSFORMATION

• Dow Jones·05/13 20:01

  *Macrogenics Guidance Extended Based on Anticipated Closing of Manufacturing Divestiture >MGNX

• Dow Jones·05/13 20:01

  Press Release: MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation

• Dow Jones·05/13 20:01

  *Macrogenics Cash Runway Guidance Extended Through 2028>MGNX

• Benzinga·05/12 17:06

  12 Health Care Stocks Moving In Tuesday's Intraday Session

• TipRanks·05/12 12:56

  MacroGenics Sells Maryland Biologics Manufacturing to Bora